EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Twin Capital Management Inc. Sells 5,541 Shares of Amgen Inc. $AMGN
Renaissance Group LLC Lowers Position in Amgen Inc. $AMGN
Jim Cramer Says Stocks Like Johnson & Johnson "Simply Refuse to Quit"
Argus Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock
Amgen (NASDAQ:AMGN) Price Target Raised to $347.00
Amgen (NASDAQ:AMGN) Price Target Raised to $295.00
Aurdan Capital Management LLC Sells 5,316 Shares of Amgen Inc. $AMGN - Markets Daily
3,190 Shares in Amgen Inc. $AMGN Acquired by ABN AMRO Bank N.V.
Amgen Refocuses Portfolio As Eczema Exit And Tavneos Review Raise Questions
Top Medical Stocks To Add to Your Watchlist - February 4th - Stock Observer
RBC Lifts Amgen (AMGN) Target After Strong Q4, Cites Key Drug Momentum
Amgen Inc. $AMGN Shares Sold by Envestnet Asset Management Inc.
Is It Time To Reassess Amgen (AMGN) After Strong Recent Share Price Gains
Morgan Stanley Issues Positive Forecast for Amgen (NASDAQ:AMGN) Stock Price - Daily Political
Dow Climbs as Amgen Leads Blue-Chip Rebound; Tech Selloff Drags Nasdaq Lower
Stocks making the biggest moves midday: MGM, AMGN, AMD, ENPH
Cantor Fitzgerald Increases Amgen (NASDAQ:AMGN) Price Target to $350.00
Amgen (NASDAQ:AMGN) Sets New 1-Year High Following Strong Earnings
Morgan Stanley Issues Positive Forecast for Amgen (NASDAQ:AMGN) Stock Price - Markets Daily
Withdraw Tavneos from market? Amgen tells FDA no | BioWorld
Amgen's Diversified Portfolio and Growing Cardiovascular Focus Support a Wide Moat | Morningstar
Morgan Stanley Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock
The Goldman Sachs Group Issues Positive Forecast for Amgen (NASDAQ:AMGN) Stock Price
Royal Bank Of Canada Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock
Leerink Partners Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock - Markets Daily
Amgen (NASDAQ:AMGN) Price Target Raised to $355.00
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and BeOne Medicines (ONC) | Markets Insider
Amgen Drops Eczema Drug Pact As Investors Weigh R&D Focus And Valuation - Simply Wall St News
The Goldman Sachs Group Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock - Daily Political
Amgen (NASDAQ:AMGN) Stock Unloaded Rep. David Taylor
Rep. David Taylor Buys Shares of Amgen Inc. (NASDAQ:AMGN)
Amgen thumbs-down on FDA's ask, Tavneos sales continue | BioWorld
Amgen ends Rocatinlimab collaboration with Japan's Kyowa Kirin
Repotrectinib in NTRK fusion-positive advanced solid tumors: a phase 1/2 trial
Amgen (NASDAQ:AMGN) Issues Earnings Results - Markets Daily
Amgen (NASDAQ:AMGN) Releases Earnings Results, Beats Expectations By $0.53 EPS - Markets Daily
Amgen Q4 Earnings Call Highlights | MarketBeat
Amgen (NASDAQ:AMGN) Updates FY 2026 Earnings Guidance
Amgen (NASDAQ:AMGN) Issues Quarterly Earnings Results, Beats Expectations By $0.55 EPS
Amgen (NASDAQ:AMGN) Reports Upbeat Q4 CY2025
Amgen sees FY26 CapEx $2.6B; share repurchases not to exceed $3B | Markets Insider
Amgen sees FY26 adjusted EPS $21.60-$23.00, consensus $22.14 | Markets Insider
Amgen reports Q4 adjusted EPS $5.29, consensus $4.76 | Markets Insider
Amgen quarterly results beat Street estimates on higher sales, lower tax rate
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS | Morningstar
Amgen Lawsuit Over 340B Discounts As Stock Trades Near Valuation Targets
Amgen options imply 3.4% move in share price post-earnings | Markets Insider
Amgen Inc. Q4 Profit Rises
Jim Cramer on Amgen: "The Biotech Really Impressed Me With a Very Strong Pipeline"
Amgen Q4 25 Earnings Conference Call At 4:30 PM ET
AlphaQuest LLC Makes New Investment in Amgen Inc. $AMGN
Will Exiting Rocatinlimab Reshape Amgen's (AMGN) Immunology Focus and Broader R&D Narrative? - Simply Wall St News
Amgen News | Markets Insider
Steve Jobs' Son Enters Venture Capital Field, Raises $200M to Combat Cancer
AMGN: Obesity And Cardiovascular Pipeline Will Shape Long-Term Cash Generation
Regulatory clarity lifts Aquestive despite CRL for Anaphylm | BioWorld
Principal Financial Group Inc. Lowers Holdings in Amgen Inc. $AMGN
United Community Bank Sells 3,842 Shares of Amgen Inc. $AMGN
Amgen quits Kyowa Kirin deal, returns rocatinlimab | BioWorld
Kyowa Kirin (TSE:4151) Regains Rocatinlimab Control Is Its R&D Strategy Entering a New Phase? - Simply Wall St News
Amgen (AMGN) Reports Q4: Everything You Need To Know Ahead Of Earnings
Amgen Refocuses Pipeline As Rocatinlimab Exit Reshapes Dermatology Outlook
Atle Fund Management AB Decreases Holdings in Amgen Inc. $AMGN
Amgen Lawsuit And Eczema Drug Exit Reframe Risk And R&D Priorities - Simply Wall St News
Alpha Cubed Investments LLC Reduces Holdings in Amgen Inc. $AMGN
Sagebrush Lawsuit Tests Amgen 340B Practices And Investor Risk Views
Amgen (NASDAQ:AMGN) Reaches New 1-Year High - Should You Buy? - Stock Observer
IgG4-Related Disease Market Size is Projected to grow at a CAGR of 34.60% by 2034, estimates DelveInsight
UBS Raises Amgen (AMGN) Target as Pharma and Biotech Setup Improves
Amgen Inc. $AMGN Shares Sold by New York State Common Retirement Fund
AE Wealth Management LLC Purchases 18,798 Shares of Amgen Inc. $AMGN
Amgen Inc. $AMGN Shares Sold by JSF Financial LLC - Daily Political
Amgen Inc. $AMGN Shares Sold by Great Lakes Advisors LLC - Daily Political
Amgen Inc. $AMGN Stake Increased by Fidelis Capital Partners LLC - Daily Political
Amgen Faces 340B Legal Challenge As Stock Trades Near Analyst Views
Amgen (NASDAQ:AMGN) Sets New 12-Month High - What's Next?
Amgen Inc. $AMGN is Federated Hermes Inc.'s 10th Largest Position
Amgen Inc. $AMGN Shares Sold by Bank of New York Mellon Corp
Amgen Lawsuit Over 340B Discounts Puts Pricing And Policy In Focus
Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial
Is It Time To Reassess Amgen (AMGN) After Strong Multi Year Share Price Gains
Amgen (AMGN) to Release Quarterly Earnings on Tuesday
Bernstein Calls 2026 a "Waiting Year" for Amgen's (AMGN) MariTide
Mutual of America Capital Management LLC Sells 3,290 Shares of Amgen Inc. $AMGN - Daily Political
15 Best S&P 500 Dividend Stocks to Buy in 2026
Recommendations for the use of CLASI as an outcome measure in cutaneous lupus erythematosus clinical trials
Will 340B Lawsuit Over Drug Discounts Shift Amgen's (AMGN) Access Strategy And Investment Narrative?
Whittier Trust Co. Acquires 39,111 Shares of Amgen Inc. $AMGN
Investment House LLC Has $7.31 Million Stake in Amgen Inc. $AMGN
Amgen Inc. $AMGN Shares Sold by AMF Tjanstepension AB
UniSuper Management Pty Ltd Acquires 6,911 Shares of Amgen Inc. $AMGN
Amgen Inc. $AMGN Shares Sold by Strs Ohio | MarketBeat
Modera Wealth Management LLC Sells 2,434 Shares of Amgen Inc. $AMGN - Stock Observer
Assessing Amgen (AMGN) Valuation After The New Sagebrush 340B Lawsuit
Amgen News
Gold price forecast: XAU/USD is above $4,900, is gold market expected to rise?
AI stocks and investment opportunities: What are the best ai stocks to invest in?
Bitcoin price prediction: Will bitcoin outperform stocks and gold in 2026?
